| Term 
 | Definition 
 
        | *Clinical effects or pharmacokinetics of a drug are altered by administration of a combination of drugs |  | 
        |  | 
        
        | Term 
 
        | Determining Clinical Significance of Drug Interaction |  | Definition 
 
        | 1. Onset (rapid/delayed) 2. Severity (major, moderate, minor)
 3. Documentation (studies, reports)
 4. Drugs with narrow therapeutic window
 |  | 
        |  | 
        
        | Term 
 
        | Two Mechanisms of Drug Interactions |  | Definition 
 
        | Pharmacodynamic or Pharmacokinetic |  | 
        |  | 
        
        | Term 
 
        | Pharmacodynamic Drug interactions |  | Definition 
 
        | one drug induces a change in a patient's response to a drug without altering the pharmacokinetics *Antagonistic or Synergistic
 |  | 
        |  | 
        
        | Term 
 
        | Antagonistic Pharmacodynamic Drug Interactions |  | Definition 
 
        | two drugs have opposite effects, cancel each other out |  | 
        |  | 
        
        | Term 
 
        | Synergistic/Additive Pharmacodynamic Drug interactions |  | Definition 
 
        | Additive CNS effects, additive side effects, additive cardiac depression, additive arrhythmogenic effect (QT prolonged), additive anticoagulant/antiplatelet effects, additive antibacterial effects |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetic Drug Interactions |  | Definition 
 
        | one drug alters the rate or extent of ADME of another drug |  | 
        |  | 
        
        | Term 
 
        | Pharmacokinetic DI: Absorption |  | Definition 
 
        | GI motility, GI pH, Inactivation/Chelation, Altered Bacterial flora, reduced or prevented enterohepatic circulation, P-glycoprotein transporter |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | metoclopramide speeds gastric emptying |  | 
        |  |